Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boulder/denver blog main
boulder/denver top stories
crispr
2
×
detroit blog main
detroit top stories
editas medicine
fda
ipo
life sciences
nasdaq
national
national blog main
national top stories
2
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
advaxis
aimmune therapeutics
akouos
alder biopharmaceuticals
alexander hardy
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew oxtoby
What
bio
ceo
2
×
roundup
acquisitions
announced
big
bosley's
bosley’s
bridge
bucks
cas
collabs
covid
crime
crispr
daniel
deal
departure
editas
exit
gilead
gilead’s
guiding
help
introduce
ipo
katrine
medicine
medicines
month
moves
o’day
personnel
plans
sciences
surprising
transformative
week
years
Language
unset
Current search:
crispr
×
" national top stories "
×
biotech
×
ceo
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More